Zdrowie i gospodarka · 17/09/2021
FDA Announces Revised Draft Guidances for Ferric Oxyhydroxide Industry
The FDA has released revised draft guidances for industry, providing product-specific recommendations for ferric oxyhydroxide oral tablets and intravenous injectable, to support abbreviated new drug applications.